Brandon Folkes

Stock Analyst at HC Wainwright & Co.

(3.31)
# 1,046
Out of 5,044 analysts
80
Total ratings
44.05%
Success rate
5.03%
Average return

Stocks Rated by Brandon Folkes

Rani Therapeutics Holdings
Oct 21, 2025
Assumes: Buy
Price Target: $11
Current: $1.78
Upside: +517.98%
Omeros
Oct 15, 2025
Maintains: Buy
Price Target: $9$20
Current: $7.71
Upside: +159.40%
MannKind
Oct 13, 2025
Reiterates: Buy
Price Target: $11
Current: $5.42
Upside: +102.95%
Genfit
Sep 24, 2025
Maintains: Buy
Price Target: $9$7
Current: $4.17
Upside: +68.03%
Rein Therapeutics
Sep 22, 2025
Initiates: Buy
Price Target: $10
Current: $1.35
Upside: +640.74%
ANI Pharmaceuticals
Sep 17, 2025
Maintains: Buy
Price Target: $93$121
Current: $92.86
Upside: +30.30%
Valneva SE
Aug 25, 2025
Reiterates: Buy
Price Target: $18
Current: $9.32
Upside: +93.13%
Journey Medical
Aug 25, 2025
Initiates: Buy
Price Target: $13
Current: $8.02
Upside: +62.09%
Achieve Life Sciences
Aug 21, 2025
Initiates: Buy
Price Target: $12
Current: $4.68
Upside: +156.41%
Eupraxia Pharmaceuticals
Aug 20, 2025
Reiterates: Buy
Price Target: $12
Current: $5.53
Upside: +117.00%
Reiterates: Buy
Price Target: $13
Current: $3.61
Upside: +260.11%
Reiterates: Buy
Price Target: $7
Current: $1.60
Upside: +337.50%
Assumes: Buy
Price Target: $10
Current: $9.31
Upside: +7.41%
Assumes: Buy
Price Target: $44
Current: $34.82
Upside: +26.38%
Maintains: Buy
Price Target: $20$17
Current: $11.05
Upside: +53.85%
Assumes: Buy
Price Target: $29
Current: $8.60
Upside: +237.21%
Initiates: Buy
Price Target: $28
Current: $24.78
Upside: +12.99%
Assumes: Buy
Price Target: $20
Current: $10.50
Upside: +90.48%
Initiates: Buy
Price Target: $26
Current: $11.08
Upside: +134.66%
Initiates: Buy
Price Target: $6
Current: $1.18
Upside: +408.47%
Assumes: Buy
Price Target: $5
Current: $1.91
Upside: +161.78%
Initiates: Buy
Price Target: $9
Current: $1.22
Upside: +637.70%
Initiates: Buy
Price Target: $21
Current: $10.50
Upside: +100.00%
Initiates: Buy
Price Target: $5
Current: $1.14
Upside: +338.60%
Initiates: Buy
Price Target: $8
Current: $0.36
Upside: +2,092.38%
Reiterates: Buy
Price Target: $16
Current: $9.69
Upside: +65.12%
Initiates: Buy
Price Target: $455
Current: $18.99
Upside: +2,296.00%
Reiterates: Overweight
Price Target: $59
Current: $30.51
Upside: +93.38%
Reiterates: Overweight
Price Target: $180
Current: $139.33
Upside: +29.19%
Maintains: Overweight
Price Target: $300$220
Current: $3.80
Upside: +5,689.47%
Upgrades: Overweight
Price Target: $28$32
Current: $29.72
Upside: +7.67%
Initiates: Overweight
Price Target: $22,000
Current: $1.57
Upside: +1,401,173.89%
Maintains: Overweight
Price Target: $42$50
Current: $17.39
Upside: +187.52%